Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Abbott Laboratories

Stocks Close Lower on Heightened Geopolitical Risks and Soaring Bond Yields

What you need to know… The S&P 500 Index ($SPX ) (SPY ) on Wednesday closed down -1.34%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.98%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.41%. Stocks on Wednesday closed sharply lower, with the...

Barchart

Abbott Laboratories (ABT) Earnings Insights: Will the Medical Stock Build Investor Confidence?

Considering Abbott Laboratories' (ABT) recent strategic collaborations and acquisitions to boost the company’s long-term growth, could the stock be a compelling buy as we approach its fiscal third-quarter earnings release? Let's find out.

StockNews.com

Worried About a Recession? Protect Your Portfolio With These 3 Resilient Stocks

With geopolitical tensions rising, here are three stocks from different sectors that have the ability to weather this storm.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Building Wealth with Spinoffs: How Adding These Gems Can Transform Your Portfolio

Spinoffs are value creating investment opportunities. You should be looking at them

Barchart

Abbott’s COVID-19 test sales dive by nearly 90%

Abbott Laboratories’ sales of COVID-19 tests fell by a whopping 89% during the second quarter of this year compared with the same time last year — a drop that comes as the world attempts to move on from the pandemic.

Chicago Tribune

Humira, the world’s top-selling drug, faces an upcoming test from low cost alternatives

If you’re one of the millions of Americans taking the prescription medication Humira, get ready to add the word biosimilars to your conversations with your doctor.

Tribune News Service

Best Medical Stock Investors Should Buy in a Recession

Despite the cooling down of inflation, a Fed rate cut is not in sight. Amid recessionary concerns, investing in medical stock Abbott Laboratories (ABT) could be wise given its sound financials and the inherent stability of the medical sector. Let’s take a look at some of the company’s key metrics….

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

3 Stocks That Could Deliver Healthy Returns This Year

The stock market will likely stay under pressure this year, with stubborn inflation and elevated interest rates. However, the Fed’s decision could largely be influenced by concerns about the recent banking crisis. Amid such uncertainty, fundamentally sound stocks Johnson & Johnson (JNJ), Abbott Laboratories (ABT), and Humana (HUM) could be…

StockNews.com

3 Health Care Stocks to Buy in a Heartbeat

The healthcare industry is expanding, fueled by the increasing demand and advancements such as personalized medicines and telehealth. Hence, fundamentally strong healthcare stocks Abbott Laboratories (ABT), Centene (CNC), and McKesson (MCK) might be worth buying in 2023. Read more.

StockNews.com

3 Health Care Stocks That Have Just What the Doctor Ordered

An aging population and innovation in treatments should continue to bode well for the healthcare sector for the longer term. With healthcare being vital for well-being and wallet, one could invest in quality healthcare stocks Thermo Fisher Scientific (TMO), Abbott Laboratories (ABT), and Centene Corp. (CNC). Read on….

StockNews.com

Abbott faces a second FTC investigation over baby formula shortage

Abbott Laboratories is facing another investigation into its role in last year’s baby formula shortage that left millions of American families scrambling for vital nutrition products.

Tribune News Service

3 Medical Stocks with Excellent Vital Signs and 1 to Avoid

Amid strong demand for medical products, technological advancements, and government support, the healthcare industry’s growth prospect looks promising in the near future. Therefore, quality medical stocks UnitedHealth Group (UNH), Abbott Laboratories (ABT), and Nature’s Sunshine Products (NATR) might be solid buys now. However, fundamentally weak SNDL Inc. (SNDL) might be…

StockNews.com

5 No-Brainer Medical Stocks to Buy in 2023

With expanding medical needs and technological advancements, the healthcare industry’s prospects look impressive. Moreover, healthcare stocks tend to perform relatively well, irrespective of economic conditions, thanks to the inelastic demand for their products and services. Therefore, we think Nature’s Sunshine Products (NATR), Abbott Laboratories (ABT), Humana (HUM), Molina Healthcare (MOH),…

StockNews.com

Abbott baby formula plant under investigation by DoJ after dire shortages

The US Justice Department is investigating the Abbott Laboratories infant formula plant in Michigan that was shut down for months last year due to contamination, the company confirmed

The Independent UK

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Justice Department investigating Abbott baby formula plant

The U.S. Justice Department is investigating the Abbott Laboratories infant formula plant in Michigan that was shut down for months last year due to contamination, the company confirmed

StockNews.com

3 Medical Device Stocks to Watch Right Now

With the healthcare industry expected to grow significantly in the coming years, the demand for medical equipment will remain strong. Therefore, it could be wise to add fundamentally strong medical device stocks Abbott (ABT), Medtronic (MDT), and Utah Medical Products (UTMD) to your watchlist now. Continue reading.

StockNews.com

3 Resilient Stocks to Own With a Recession Looming

With the Fed more than willing to risk recession with continued interest rate hikes, it would be wise to invest in shares of Coca-Cola (KO), Abbott (ABT), and Waste Management (WM), which have resilient business models, robust demand, and consistent income generation potential. Continue reading….

Reason

Guest Post from Professor John Harrison: Vacatur's Missing Pedigree

I'm delighted to post a summary from Professor John Harrison of his forthcoming article Vacatur of Rules Under the Administrative Procedure Act. Professor Harrison's work was recently highlighted by Professor Amanda Frost at SCOTUSBlog as one side of a debate critical to United States v. Texas, which will be argued…

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

2 Medical Stocks to Buy Now for Long-Term Resilience

Healthcare industry tends to perform relatively well despite macroeconomic headwinds, thanks to near-inelastic demand for their products and services. So, we believe quality medical stocks UnitedHealth Group (UNH) and Abbott (ABT) might be ideal Buys for the long term. Keep reading….

StockNews.com

3 Attractively Priced Stocks to Buy This Week

The Fed’s continued hawkish monetary policy stance has raised fears of an impending recession. Despite the market pressure, the U.S. GDP saw a positive turnaround in the third quarter of 2022, indicating a resilient economy. Amid this scenario, we think investors should buy fundamentally sound stocks Abbott Laboratories (ABT), Verizon…

StockNews.com

Buying These 2 Stocks Could Be the Best Move You Ever Make

With an albeit decelerating yet solid employment report for October playing into the rationale for slower yet surer hikes by the Fed, the economy seems to be on the brink of a recession. Amid an uncertain economic backdrop, It could be wise to invest in fundamentally strong stocks, Abbott Laboratories…

StockNews.com

5 Stocks to Keep Your Portfolio Safe During a Bear Market

With inflation hovering around the multi-decade high level, further aggressive interest rate hikes seem apparent. Given the weak market outlook, investors could cushion their portfolios by investing in fundamentally sound stocks PepsiCo (PEP), Cisco Systems (CSCO), Abbott Laboratories (ABT), Albertsons Companies (ACI), and Hillenbrand (HI), which have a history of…

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 26, 2022

Upgrades

StockNews.com

Is It Too Late to Make Money on ABT Stocks This Fall?

Despite the uncertain macro environment, Abbott (ABT) increased its adjusted EPS guidance for 2022. Wall Street analysts expect it to rally more than 20% in the near term. However, the stock is down 30% year-to-date. So, let's find out if it is the right time to invest in ABT….

Tribune News Service

Abbott plans a new $500M baby-formula plant to increase U.S. capacity for the vital product

Abbott Laboratories is building a new infant-formula manufacturing plant after the product shortage of the past year revealed gaps in U.S. production capacity.

1 … 3 4 5 6

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Dow Jones Industrials

308 stories

Abbott

292 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.